window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 2, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Advanced Therapies
  • Biotech & Pharma Business
  • Central Nervous System
  • Clinical & Regulatory
  • Digital & Data
  • Drug Delivery & Formulation
  • Drug Discovery & Development
  • Genomics and sequencing
  • Manufacturing & Supply Chain
  • Medical devices
  • Opinion & Events
  • Pharmaceuticals and therapeutics
  • Therapeutic Areas
  • Uncategorised
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    FairJourney Bio opens cryo-EM facility in San Diego for antibody discovery

    read more
  • Drug Discovery & Development,Therapeutic Areas

    Kinesin-2 motor variants shown to control cargo transport in neurons

    read more
  • Central Nervous System,Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome

    read more
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Currax highlights peer-reviewed review supporting combination approaches in obesity treatment

    read more
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD

    read more
  • Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Symbiosis expands QC capabilities with new 30°C stability chamber

    read more
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed

    read more
  • Digital & Data,Drug Discovery & Development

    Chemify founder publishes three papers on programmable chemistry and automated drug discovery

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    European liver experts highlight rising MASLD burden at EASL symposium in Budapest

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Pharmaceuticals and therapeutics,Therapeutic Areas

    Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy

    read more
  • Clinical & Regulatory,Therapeutic Areas

    Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth

    read more
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board

    read more
  • Weite Oldenziel
    Manufacturing & Supply Chain

    Ofichem unifies CDMO and pharmaceutical supply brands under single identity

    read more
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development

    read more
  • Digital & Data,Drug Discovery & Development

    William Blair highlights Carterra as key player in AI-driven drug discovery shift

    read more
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Abivax to present nine obefazimod studies at DDW as Phase 3 ulcerative colitis data build
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Opinion & Events, Therapeutic Areas
  • Viz.ai, Johnson & Johnson strike US chronic subdural hematoma AI deal
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Medical devices
  • Veristat acquires Certara regulatory and medical writing business
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Digital & Data, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top